thelancet.com
Real-world effectiveness of nirsevimab against respiratory syncytial virus disease in infants: a systematic review and meta-analysis
Our findings indicate that the benefits of nirsevimab observed in clinical trials
are also evident in real-world settings, effectively reducing the burden of RSV disease
in infants and, consequently, ...